We are live on
!
Find out more
SR
Summer Road Portfolio holdings
AUM
$161M
1-Year Est. Return
27.24%
This Fund
S&P 500
This Quarter
Est. Return
+172.01%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$116M
AUM Growth
+$73.6M
(+172%)
Cap. Flow
+$6.49K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ocular Therapeutix
OCUL
|
+$6.49K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SFCM
LWM
MWM
MCM
BFS
MMCM
MWA
BWM
Summer Road's Q4 2020 Portfolio in Review
As of Q4 2020, Summer Road held 1 position worth $116M, up 172% from $42.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2020: portfolio turnover was 0%. Summer Road opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Summer Road added most to Ocular Therapeutix in Q4 2020, an estimated $6.49K increase.
- Summer Road's ten largest holdings make up 100% of its $116M portfolio in Q4 2020.
- Summer Road opened 0 new positions and closed 0 in Q4 2020.
- Summer Road's portfolio value rose 172% quarter-over-quarter to $116M.
Based on Summer Road's 13F filing for Q4 2020, filed 16 Feb 2021.